These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20025739)

  • 1. Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptors.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2009 Dec; 8():26. PubMed ID: 20025739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report.
    Kishimoto A; Todani A; Miura J; Kitagaki T; Hashimoto K
    Ann Gen Psychiatry; 2010 May; 9():23. PubMed ID: 20492642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant treatment of psychotic major depression: potential role of the sigma receptor.
    Stahl SM
    CNS Spectr; 2005 Apr; 10(4):319-23. PubMed ID: 15788959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Apr; 9():17. PubMed ID: 20416096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Mar; 9():11. PubMed ID: 20205742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
    Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
    J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's disease.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Jan; 9():6. PubMed ID: 20148109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-occurring depressive symptoms in the older patient with schizophrenia.
    Kasckow JW; Zisook S
    Drugs Aging; 2008; 25(8):631-47. PubMed ID: 18665657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sigma-1 receptor agonist fluvoxamine for delirium in intensive care units: report of five cases.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Apr; 9():18. PubMed ID: 20416097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.
    Mulsant BH; Sweet RA; Rosen J; Pollock BG; Zubenko GS; Flynn T; Begley AE; Mazumdar S; Reynolds CF
    J Clin Psychiatry; 2001 Aug; 62(8):597-604. PubMed ID: 11561930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment for psychotic depression.
    Wijkstra J; Lijmer J; Burger H; Geddes J; Nolen WA
    Cochrane Database Syst Rev; 2013 Nov; (11):CD004044. PubMed ID: 24282034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on psychotic depression.
    Hamoda HM; Osser DN
    Harv Rev Psychiatry; 2008; 16(4):235-47. PubMed ID: 18661366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sigma-1 receptor agonist fluvoxamine for postoperative delirium in older adults: report of three cases.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Jun; 9():28. PubMed ID: 20573265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and efficacy of fluvoxamine and amitriptyline in depression.
    Vezmar S; Miljkovic B; Vucicevic K; Timotijevic I; Prostran M; Todorovic Z; Pokrajac M
    J Pharmacol Sci; 2009 May; 110(1):98-104. PubMed ID: 19444001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine in the treatment of depression with psychotic features: A prospective open-label study.
    Adli M; Wiethoff K; Baethge C; Pfennig A; Stamm T; Bauer M
    Int J Psychiatry Clin Pract; 2008; 12(3):202-9. PubMed ID: 24931659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state.
    Medda P; Perugi G; Zanello S; Ciuffa M; Rizzato S; Cassano GB
    J ECT; 2010 Jun; 26(2):82-6. PubMed ID: 19710623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.
    Kasper S; Möller HJ; Montgomery SA; Zondag E
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():3-12. PubMed ID: 7622821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.